Consumption of sucrose-sweetened soft drinks increases plasma levels of uric acid in overweight and obese subjects: A 6-month randomised controlled trial

European Journal of Clinical Nutrition

Volumn 69, Issue 8, 2015, Pages 949-953

  Bruun, J M ^a,b   Maersk, M ^a   Belza, A ^c   Astrup, A ^c   Richelsen, B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b RANDERS REGIONAL HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; DRINKING WATER; SUGAR INTAKE; SWEETENING AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BONE MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FAT MASS; FEMALE; FLUID INTAKE; FOOD COMPOSITION; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MALE; MILK; OBESITY; SOFT DRINK; SUBCUTANEOUS FAT; SUCROSE SWEETENED SOFT DRINK; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; CARBONATED BEVERAGE; COMPLICATION; LIVER; METABOLIC DISEASES; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUGAR INTAKE; TIME FACTOR;

ADULT; ANIMALS; CARBONATED BEVERAGES; DIETARY SUCROSE; DRINKING WATER; FEMALE; HUMANS; INSULIN; LIVER; MALE; METABOLIC DISEASES; MIDDLE AGED; MILK; OBESITY; OVERWEIGHT; RISK FACTORS; SWEETENING AGENTS; TIME FACTORS; TRIGLYCERIDES; URIC ACID;

EID: 84938991569     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2015.95     Document Type: Article

References (20)

1. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/ obese humans. J Clin Invest 2009; 119: 1322-1334
2. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010; 299: E685-E694
3. Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 2012; 56: 952-960
4. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 2007; 292: F423-F429
5. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631
6. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC et al. Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/ obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. J Clin Endocrinol Metab 2011; 96: E2034-E2038
7. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC et al. Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr Metab (Lond) 2012; 9: 68
8. Sluijs I, Beulens WJ, Van Der A DL, Spijkerman AMW, Schulze MB, Van Der Schouw YT. Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J Nutr 2013; 143: 80-85
9. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013; 62: 3307-3315
10. Maersk M, Belza A, Stødkilde-Jørgensen H, Ringgaard S, Chabanova E, Thomsen H et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 2012; 95: 283-289
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
12. Sievenpiper JL, De Souza RJ, Cozma AI, Chiavaroli L, Ha V, Mirrahimi A. Fructose vs glucose and metabolism: do the metabolic differences matter?. Curr Opin Lipidol 2014; 25: 8-19
13. Wang DD, Sievenpiper JL, De Souza RJ, Chiavaroli L, Ha V, Cozma AI et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 2012; 142: 916-923
14. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr 1993; 58 (suppl): 754S-765SS.
15. The InterAct consortium. Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 2013; 56: 1520-1530
16. Xu Y, Zhu J, Gao L, Liu Y, Shen J, Shen C et al. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-Analysis. PLoS One 2013; 8: e78206
17. Jia L, Xing J, Ding Y, Shen Y, Shi X, Ren W et al. Hyperuricemia causes pancreatic beta-cell death and dysfunction through NF-kappaB signaling pathway. PLoS One 2013; 10: e78284
18. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005; 11: 191-198
19. Herder C, Haastert B, Müller-Scholze S, Koenig W, Thorand B, Holle R et al. Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the cooperative health research in the region of Augsburg survey S4 (KORA S4). Diabetes 2005; 54: S11-S17
20. Baldwin W, McRay S, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011; 60: 1258-1269